(Nasdaq: GRCE) formerly Acasti Pharma Inc. (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being ...

An intravenous (IV) fluid shortage in the wake of Hurricane Helene is continuing after a major North Carolina factory was ...

While intravenous propofol is a first-choice drug for use in painless gastrointestinal endoscopy, it is known to have inhibitory effects on the respiratory and circulatory systems and is associated ...

Six months after the attack on Pearl Harbor, there were over 12,000 women acting as nurses within the military. Most of them ...

The launch of the lyophilized powder for injection containing 100 mg of paclitaxel in a single-dose vial for intravenous use follows approval by the FDA on Oct. 8, 2024. Keren Haruvi, president of ...

No significant relationship was identified between body weight and the persistence of either intravenous or subcutaneous tocilizumab among patients with rheumatoid arthritis. Body weight may influence ...

As the nation’s largest supplier of intravenous fluids works to return to full production in North Carolina, Self Regional ...

The home infusion industry is experiencing significant growth due to the increasing number of aging patients wanting to ...

Tocilizumab treatments in patients with noninfectious uveitis demonstrated high rates of success at 1 year follow ups.

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Read about Baxter's progress in restoring its North Cove facility after Hurricane Helene-related flooding, causing widespread shortages and a $200 million loss.